Abstract

For the past decade, lidocaine 2% gel has been one of the more commonly used agents for topical anesthesia in cataract surgery, particularly in the USA. Given its prolonged contact time with the ocular surface by nature of its viscosity, it has been found to provide superior anesthesia relative to anesthetic drops. A downside to this inexpensive and efficacious agent is that it was never intended to be used for ophthalmic surgery and, as a result, is packaged in a tube rendering it somewhat messy to apply. TetraVisc™ is a high-viscosity formulation of tetracaine hydrochloride 0.5% that is packaged in a sterile ophthalmic dropper bottle. A single report in the literature suggests that it is of equal efficacy to lidocaine 2% gel as a topical anesthetic for routine cataract surgery.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.